eXceed Events: Americas 2025
eXceed Events Americas
Explore innovative solutions in proteomics, metabolomics/lipidomics, MALDI Imaging, and pharma/biopharma. Discover how Bruker can transform your multiomics research, connect with industry experts and network with like-minded professionals.
Don't miss out on this chance to eXceed your potential and achieve new heights in your research. Meet our team at various locations across the Northeast, Southwest, West, Southeast, and Midwest regions. Register and secure your spot today!
Midwest
Coming soon!
Northeast
Coming soon!
Northwest
Coming soon!
West
Discover More! Bruker's Latest Innovations
September 25, 2025
11:00 am - 1:00 pm PT
Location: UCSF, Mission Hall, Room 1406, 550 16th Street, San Francisco, CA 94158
Agenda:
11:00 - 11:10 am Check In
11:10 - 11:15 am Welcome
Liling Fang, Ph.D., Senior Sales Account Manager, Bruker Scientific LLC, San Jose, CA, USA
11:15 - 11:35 am Every Cell Counts, Every Peptide Matters: from large scale studies to smallest single cells, see more with timsUltra AIP
Daniel Hornburg, Ph.D., Vice President, Biomarkers & Precision Medicines, Bruker Scientific LLC, San Jose, CA, USA
11:35 - 11:55 am Discover MoRE with timsMetabo for small molecule bioanalysis research
Erica Forsberg, Ph.D., Vice President Metaoblomics, Bruker Scientific LLC, San Diego, CA, USA
11:55 am - 12:10 pm Break and pick up boxed lunch
12:10 - 12:25 pm neofleX™ – A new platform for uses from standard MALDI biologics analysis to MALDI Imaging
Nannan Tao, Ph.D., MALDI Applications Manager, Bruker Scientific LLC, San Jose, CA, USA
12:25 - 12:45 pm Innovations for deep proteoform sequencing and structural elucidation
Guillaume Tremintin, Innovations Technical Senior Manager, Bruker Scientific LLC, San Jose, CA, USA
12:45 - 1:00 pm Questions and Answers
Southwest
Coming soon!
Southeast
NIH Research Festival 2025 - Bruker Biosensors Workshop on the Biophysical Characterization of Biologics
September 11, 2025
10:00 - 11:00 am EDT
Location: NIH Bethesda campus, NIH Clinical Center, Building 10, FAES Classroom 3&4, Bethesda, Maryland, USA
From Ions to Insights: Integrating Mass Spectrometry and Spatial Omics
October 6, 2025
12:00 - 4:00 pm EDT
Location: Bryan Research Building Room 103 (the Bryan Auditorium), Duke University, Durham, NC, USA
Agenda:
12:00 - 12:15 pm Welcome and Introductions
Erik Soderblom, Ph.D., Director, Proteomics & Metabolomics, Associate Research Professor of Cell Biology, Duke University, Durham, NC, USA
12:15 - 1:00 pm Spatial Mapping and Cartography – A New Era in Lung Tumor Mapping
Rajkumar Savai, Ph.D., Professor, Institute for Lung Health, Justus Liebig University Giessen, Germany
1:00 - 1:30 pm Spatial alignment approaches for near-serial section multi-omic experiments
Aditya Pratap, Ph.D., Postdoctoral Associate, Departments of Cell Biology and Biostatistics and Bioinformatics, Duke University, Durham, NC, USA
1:30 - 2:10 pm Break for refreshments
2:10 - 2:15 pm Introductions
Brittni Woodall, Ph.D., Account Manager, Bruker, Hickory, NC, USA
2:15 - 3:00 pm Bringing Disease into Focus with Integrative Multimodal Imaging Mass Spectrometry
Jeff Spraggins, Ph.D. Associate Professor of Cell & Developmental Biology and Director of the Mass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA
3:00 - 3:30 pm Metabolic Landscaping of Tissues and Circulating Immune Cells by Mass Spectrometry Imaging
Lyndsay Young, Ph.D., Postdoctoral Fellow, Department of Pharmacology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA
3:40 - 4:00 pm Closing Remarks
Disclaimer
As you are certainly aware, special compliance regulations apply to public officials* and healthcare professionals** with regard to the event we are planning. If you accept our invitation, we will therefore assume that you will observe the compliance regulations that apply to you and that you have the necessary employer approval.
* Government Official means according the Bruker policies any of the following: any officer, employee or representative of a government (national, regional or local) entity, or any public agency, public authority, department or instrumentality thereof, regardless of their rank or title (e.g. a regulatory official or government inspector); any person working for or advising a government-owned or government-controlled enterprise (e.g. a professor at a government-owned university, or a purchaser at a government-owned hospital); any person working for or advising a national or international non-governmental organization (e.g. an employee of the Red Cross or The World Bank); any person performing a public function or providing a public service, even if that person works for a nongovernmental institution (e.g. private security personnel working in public functions); any person hired to review or accept bids for a government agency; any person with the responsibility to allocate or expend government funds; any person in a public law function, civil servant, judge or military personnel; any person acting for a political party, including party officials, candidates or individuals holding a position in a political party office; members of royal families; or immediate family members of any of the persons listed above. An immediate family member is a grandparent, parent, spouse, significant other, child, or sibling.
** A Healthcare Professional (HCP) is in accordance with the Bruker policies any physician, dentist, nurse, pharmacist or other individual who may prescribe, administer, purchase, dispense, recommend, or supply medical products or treatments or pharmaceutical products. In many cases, Bruker interacts with HCPs who work for state-owned hospitals (e.g. as medical scientists). These individuals will be classified as both HCPs and Government Officials.
For Research Use Only. Not for use in clinical diagnostic procedures.